X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
adult (5) 5
antiretroviral therapy (5) 5
female (5) 5
humans (5) 5
male (5) 5
adolescent (4) 4
adults (4) 4
clinical trials (4) 4
hiv (4) 4
hiv infections - drug therapy (4) 4
immunology (4) 4
infectious diseases (4) 4
middle aged (4) 4
young adult (4) 4
africa (3) 3
aged (3) 3
antiretroviral drugs (3) 3
cd4 antigen (3) 3
child (3) 3
children (3) 3
drug therapy (3) 3
human immunodeficiency virus--hiv (3) 3
isoniazid - therapeutic use (3) 3
mortality (3) 3
risk (3) 3
abacavir (2) 2
africa south of the sahara (2) 2
aids/hiv (2) 2
anti-retroviral agents - administration & dosage (2) 2
anti-retroviral agents - therapeutic use (2) 2
antiretroviral agents (2) 2
antitubercular agents - therapeutic use (2) 2
biology and life sciences (2) 2
cd4 lymphocyte count (2) 2
child, preschool (2) 2
dosage and administration (2) 2
efavirenz (2) 2
highly active antiretroviral therapy (2) 2
hiv infections - complications (2) 2
hiv infections - mortality (2) 2
hiv patients (2) 2
human immunodeficiency virus (2) 2
isoniazid (2) 2
medical research (2) 2
medicine and health sciences (2) 2
medicine, general & internal (2) 2
morbidity (2) 2
peripheral neuropathy (2) 2
prevalence (2) 2
raltegravir potassium - administration & dosage (2) 2
research and analysis methods (2) 2
sensory neuropathy (2) 2
stavudine (2) 2
tenofovir (2) 2
therapy (2) 2
tuberculosis (2) 2
uganda - epidemiology (2) 2
virology (2) 2
zimbabwe - epidemiology (2) 2
abridged index medicus (1) 1
acquired immune deficiency syndrome (1) 1
acquired immune deficiency syndrome--aids (1) 1
active antiretroviral therapy (1) 1
adolescence (1) 1
adolescents (1) 1
advanced hiv disease (1) 1
adverse events (1) 1
africa - epidemiology (1) 1
africa south of the sahara - epidemiology (1) 1
aids (1) 1
aids-related opportunistic infections - prevention & control (1) 1
albendazole (1) 1
alcohol abstinence (1) 1
amplification (1) 1
analysis (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - therapeutic use (1) 1
anti-infective agents - administration & dosage (1) 1
anti-infective agents - adverse effects (1) 1
anti-infective agents - therapeutic use (1) 1
anti-retroviral agents - adverse effects (1) 1
antiretroviral therapy, highly active (1) 1
antiviral agents (1) 1
arachis (1) 1
article (1) 1
association (1) 1
azithromycin (1) 1
bilirubin (1) 1
biological products industry (1) 1
biomarkers (1) 1
biomedicine (1) 1
body mass index (1) 1
body weight (1) 1
candidiasis (1) 1
cd4-positive t-lymphocytes - drug effects (1) 1
cd4-positive t-lymphocytes - pathology (1) 1
cd4-positive t-lymphocytes - virology (1) 1
councils (1) 1
creatinine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 3, pp. 233 - 245
Journal Article
PLoS medicine, ISSN 1549-1676, 12/2018, Volume 15, Issue 12, p. e1002706
Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting... 
MORTALITY | BIOMARKERS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | IMMUNE RECONSTITUTION | EFAVIRENZ | ADULTS | INFECTION | RESTORATION | IMMUNODEFICIENCY | CHILDREN | HIV Infections - diagnostic imaging | Africa - epidemiology | Zimbabwe - epidemiology | Drug Administration Schedule | Follow-Up Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Raltegravir Potassium - administration & dosage | Child, Preschool | Malawi - epidemiology | Uganda - epidemiology | Male | Disease Progression | Anti-HIV Agents - administration & dosage | Young Adult | Anti-Retroviral Agents - administration & dosage | Adolescent | Adult | Female | HIV Infections - drug therapy | Child | Health Services Accessibility - trends | Drug therapy | HIV infection | Raltegravir | Testing | Adolescence | Therapy | RNA-directed DNA polymerase | Viremia | Funding | Clinical trials | Risk | Viruses | Infections | Tenofovir | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Children | Adolescents | Genotypes | Supervision | University colleges | Integrase | Antiretroviral drugs | Medical research | Mortality | Immune reconstitution | Inflammation | Disease control | Antiretroviral therapy | Morbidity | CD4 antigen | Medicine | Amplification | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Councils | Abacavir | Nucleosides | Biomarkers | Mutation | HIV | Human immunodeficiency virus
Journal Article
Journal of NeuroVirology, ISSN 1355-0284, 2/2016, Volume 22, Issue 1, pp. 104 - 113
Sensory peripheral neuropathy (PN) remains a common complication in HIV-positive patients despite effective combination anti-retroviral therapy (ART). Data on... 
Neurology | Neurosciences | Biomedicine | Immunology | Second-line ART | Tuberculosis | HIV | Africa | Infectious Diseases | Peripheral neuropathy | Virology | RISK-FACTORS | PREVALENCE | SENSORY NEUROPATHY | STAVUDINE | NEUROTOXICITY | NEUROSCIENCES | VIROLOGY | ERA | ACTIVE ANTIRETROVIRAL THERAPY | INFECTED PERSONS | ADVERSE EVENTS | Humans | Middle Aged | Raltegravir Potassium - therapeutic use | Male | RNA, Viral - blood | Tuberculosis, Pulmonary - drug therapy | Peripheral Nervous System Diseases - physiopathology | CD4-Positive T-Lymphocytes - pathology | RNA, Viral - antagonists & inhibitors | HIV-1 - growth & development | Smoking - physiopathology | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Isoniazid - therapeutic use | CD4-Positive T-Lymphocytes - virology | Peripheral Nervous System Diseases - complications | Antitubercular Agents - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Africa South of the Sahara | Logistic Models | Alcohol Abstinence | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | Peripheral Nervous System Diseases - virology | HIV Infections - complications | HIV Infections - drug therapy | Lopinavir - therapeutic use | HIV Infections - physiopathology | Viral Load - drug effects | CD4-Positive T-Lymphocytes - drug effects | Drug Combinations | Peripheral Nervous System Diseases - drug therapy
Journal Article
by Post, Frank A and Szubert, Alexander J and Prendergast, Andrew J and Johnston, Victoria and Lyall, Hermione and Fitzgerald, Felicity and Musiime, Victor and Musoro, Godfrey and Chepkorir, Priscilla and Agutu, Clara and Mallewa, Jane and Rajapakse, Chathurika and Wilkes, Helen and Hakim, James and Mugyenyi, Peter and Sarah Walker, A and Gibb, Diana M and Pett, Sarah L and Kityo, C and Wavamunno, P and Nambi, E and Ocitti, P and Ndigendawani, M and Portal, F and Kabahenda, S and Kemigisa, M and Acen, J and Olebo, D and Mpamize, G and Amone, A and Okweny, D and Mbonye, A and Nambaziira, F and Rweyora, A and Kangah, M and Kabaswahili, V and Abach, J and Abongomera, G and Omongin, J and Aciro, I and Philliam, A and Arach, B and Ocung, E and Amone, G and Miles, P and Adong, C and Tumsuiime, C and Kidega, P and Otto, B and Apio, F and Baleeta, K and Mukuye, A and Abwola, M and Ssennono, F and Baliruno, D and Tuhirwe, S and Namisi, R and Kigongo, F and Kikyonkyo, D and Mushahara, F and Tusiime, J and Musiime, A and Nankya, A and Atwongyeire, D and Sirikye, S and Mula, S and Noowe, N and Lugemwa, A and Kasozi, M and Mwebe, S and Atwine, L and Senkindu, T and Natuhurira, T and Katemba, C and Ninsiima, E and Acaku, M and Kyomuhangi, J and Ankunda, R and Tukwasibwe, D and Ayesiga, L and Nathoo, K and Bwakura-Dangarembizi, M and Reid, A and Chidziva, E and Mhute, T and Tinago, G.C and Bhiri, J and Mudzingwa, S and Phiri, M and Steamer, J and Nhema, R and Warambwa, C and Mutsai, S and Nemasango, B and Moyo, C and Chitongo, S and Rashirai, K and Vhembo, S and Mlambo, B and Nkomani, S and ... and Reduction EArly MortaLITY and Reduction of EArly mortaLITY in HIV-infected adults and children starting antiretroviral therapy (REALITY) Trial Team
Clinical Infectious Diseases, ISSN 1058-4838, 03/2018, Volume 66, Issue suppl_2, pp. S132 - S139
Background. In sub-Saharan Africa, 20%-25% of people starting antiretroviral therapy (ART) have severe immunosuppression; approximately 10% die within 3... 
mortality | HIV | morbidity | antiretroviral therapy | Africa | INFECTIOUS DISEASES | HIV-INFECTION | RECONSTITUTION INFLAMMATORY SYNDROME | DISEASE | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | Advanced HIV Disease
Journal Article
by Mallewa, Jane and Szubert, Alexander J and Mugyenyi, Peter and Chidziva, Ennie and Thomason, Margaret J and Chepkorir, Priscilla and Abongomera, George and Baleeta, Keith and Etyang, Anthony and Etyang, Timothy and Warambwa, Colin and Melly, Betty and Mudzingwa, Shepherd and Kelly, Christine and Agutu, Clara and Wilkes, Helen and Nkomani, Sanele and Musiime, Victor and Musiime, Alex and Lugemwa, Abbas and Pett, Sarah L and Bwakura-Dangarembizi, Mutsa and Prendergast, Andrew J and Gibb, Diana M and Walker, Ann Sarah and Walker, A Sarah and Berkley, Jay and Berkley, James A and Kityo, Cissy and Wavamunno, Priscilla and Nambi, Esther and Ocitti, Paul and Ndigendawani, Milly and Kabahenda, Sheila and Kemigisa, Mable and Acen, Juliet and Olebo, David Francis and Mpamize, Gordon and Amone, Geoffrey and Amone, Alex and Okweny, David and Mbonye, Andrew and Nambaziira, Florence and Rweyora, Angela and Kangah, Mary and Kabaswahili, Beatrice and Abach, James and Omongin, Joseph and Aciro, Irene and Philliam, Aleti and Arach, Beatrice and Ocung, Emmanuel and Miles, Peter and Adong, Claudia and Tumsuiime, Constance and Kidega, Patrick and Otto, Ben and Apio, Florence and Mukuye, Andrew and Abwola, Mary and Ssennono, Fred and Baliruno, David and Tuhirwe, Stephen and Namisi, Ronald and Kigongo, Fredrick and Kikyonkyo, Dickson and Mushahara, Furaha and Tusiime, Julian and Nankya, Agnes and Atwongyeire, Dickens and Sirikye, Sowal and Myalo, Sula and Noowe, Nelson and Kasozi, Mariam and Mwebe, Sandra and Atwine, Lorna and Senkindu, Tapson and Natuhurira, Ian and Katemba, Chrispus and Ninsiima, Emily and Acaku, Moses and Kyomuhangi, Joy and Ankunda, Rogers and Tukwasibwe, Deogratious and Ayesiga, Lillian and Hakim, James and Nathoo, Kusum and Reid, Andrew and Mhute, Tawand and Tinago, Gloria and Bhiri, Joyline and Phiri, Misheck and Steamer, John and Nhema, Ruth and Musoro, Godfrey and Mutsai, Shirley and Nemasango, Beauty and Moyo, Columbus and Chitongo, Stuart and Rashirai, Kennias and ... and REALITY Trial Team and REALITY trial team
The Lancet HIV, ISSN 2352-3018, 05/2018, Volume 5, Issue 5, pp. e231 - e240
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.